Overall rank by patents
#9,580
of 50,000 tracked assignees
USPTO PatentsView assignee record - 33 granted patents across 21 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).
The verdict
According to USPTO PatentsView, OSLO ranks #9,580 of 50,000 tracked US assignees by granted-patent volume, with 33 patents across 21 technology areas.
USPTO PatentsView assignee plate
Corpus R9580 · Foreign Corporation #9,580 · 33 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: North Carolina Agricultural And Technical State University (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Curt G Joa · near
41 score
Intersect ENT · near
41 score
OSLO Universitetssyk… · this assignee
41 score
Shenzhen Sunway Comm… · near
41 score
WEST China Hospital… · near
41 score
3D Lighting Innovati… · lowest
7 score
What this shows OSLO Universitetssykehus stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-RICH, TYPE-FRNCORP, VEL-SURGE, BOOK-FULL. Volume places it #9,580 of 50,000; Innovation Score 41.1/100 sits in the top 34% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is North Carolina Agricultural And Technical State University (±0 grants).
OSLO Universitetssykehus has been granted 33 US utility patents between 2015 and 2025, placing OSLO Universitetssykehus at #9,580 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 21 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.6 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a Foreign Corporation, OSLO Universitetssykehus is one of the more focused assignees in the PatentsView dataset. By volume, OSLO sits between North Carolina Agricultural And Technical State University (33 patents, rank #9,573) and Philogen S.p.a. (33 patents, rank #9,581) - the closest US assignees by grant volume. The composite Innovation Score of 41.1/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 21 grants, compared with 10 in the 2015–2019 window, a +110% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. OSLO Universitetssykehus's 13.6 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 21 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
North Carolina Agricultural and Technical State University
33 patents
Novozymes North America Inc.
33 patents
OCULEVE, INC.
33 patents
OSAKA CITY UNIVERSITY
33 patents
OTOY INC.
33 patents
Oath (Americas) Inc.
33 patents
Optical Cable Corporation
33 patents
PHILOGEN S.P.A.
33 patents
OSLO UNIVERSITETSSYKEHUS
33 patents
What this shows OSLO holds 33 patents at rank #9,577, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #9,577 in granted patent volume.
Other assignees with the most granted patents in OSLO's primary technology class.
Two PlainPatent-derived peer sets for OSLO, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (41 here).
OSLO's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 34% higher than 66% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 3.0% |
| 2016 | 1 | 3.0% |
| 2017 | 5 | 15.2% |
| 2018 | 2 | 6.1% |
| 2019 | 1 | 3.0% |
| 2020 | 6 | 18.2% |
| 2021 | 6 | 18.2% |
| 2022 | 2 | 6.1% |
| 2023 | 3 | 9.1% |
| 2024 | 4 | 12.1% |
| 2025partial year | 2 | 6.1% |
Top 15 of 21 technology areas
Overall rank by patents
#9,580
of 50,000 tracked assignees
41.1 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.